Table 3.
Vit-D <10 ng/mL (n = 73) | Vit-D 10−20 ng/mL (n = 43) | Vit-D 20−30 ng/mL (n = 9) | Vit-D >30 ng/mL (n = 5) | pa | |||||
---|---|---|---|---|---|---|---|---|---|
TSH, mU/mL | 15.2±17.3 | 8.9 (5−100) | 12.9±10.8 | 9.0 (4−46) | 12.4±9.1 | 8 (5.6−30) | 11.6±10.4 | 7 (6−30) | 0.877 |
FT4, ng/mL | 1.0±1.0 | 0.8 (0.2−6.5) | 1.1±1.5 | 0.8 (0.4−8) | 0.9±0.1 | 0.9 (0.6−1) | 0.8±0.1 | 0.8 (0.6−0.9) | 0.579 |
Anti-TPO, IU/mL | 411.9±413.3 | 227 (4−1000) | 284.9±323.1 | 116 (5−1000) | 450.6±505.1 | 50 (5−1000) | 487.8±472.4 | 443 (6−1000) | 0.429 |
Vit-B12, pg/mL | 220.6±70.1 | 206 (116−380) | 208.6±59.1 | 189 (114−332) | 210±42.6 | 223 (128−274) | 238.2±87.6 | 250 (128−345) | 0.753 |
Age, years | 41.0±11.8 | 40 (19−62) | 42.2±12.9 | 41 (18−64) | 42.6±11.1 | 41 (30−64) | 37.4±3.4 | 36 (34−41) | 0.812 |
Vit-D ≤10 ng/mL | Vit-D ≥10 ng/mL | ||||||||
---|---|---|---|---|---|---|---|---|---|
Gender and vit-D relationship | |||||||||
Male | 5 (6.8) | 10 (17.5) | |||||||
Female | 68 (93.2) | 47 (82.5) | |||||||
Total | 73 (100) | 57 (100) |
Data are presented as the mean ± SD, median (min.–max.), and n (%).
Kruskal-Wallis test.